Table 3.
Correlations between FMD and lipid and glucose parameters at baseline and postprandially, and changes in these parameters in response to the cookie test in the bezafibrate group
|
Dependent variable, FMD |
Baseline |
4 h |
Change |
|||
|---|---|---|---|---|---|---|
| r | p | r | p | r | p | |
| TG |
-0.33 |
0.35 |
-0.21 |
-0.60 |
-0.41 |
0.24 |
| RLP-C |
-0.39 |
0.27 |
-0.15 |
0.68 |
-0.26 |
0.47 |
| ApoB-48 |
-0.39 |
0.27 |
-0.29 |
0.42 |
-0.37 |
0.29 |
| |
Baseline |
2 h |
Change |
|||
| |
r |
p |
r |
p |
r |
p |
| Glucose |
-0.47 |
0.17 |
-0.51 |
0.13 |
0.004 |
0.99 |
| Insulin |
-0.33 |
0.36 |
-0.41 |
0.24 |
0.14 |
0.7 |
| HOMA-R | -0.38 | 0.27 | -0.47 | 0.17 | 0.16 | 0.66 |
FMD, flow-mediated dilation; TG, triglyceride; RLP-C, remnant lipoprotein cholesterol; ApoB-48, apolipoprotein B-48; HOMA-R, Homeostasis model assessment ratio.